MedTrace Logo

A Study Comparing Outcomes of Kidney Transplants in Patients on Steroids Versus Those Who Discontinue Steroids

NCT00273559 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2008-05-12

No results posted yet for this study

Summary

The purpose of this study is to compare the risks and benefits of steroid elimination versus steroid therapy in renal transplant patients particularly looking at the effects on bone mass, lipids, hypertension, and new onset diabetes.

Conditions

Interventions

DRUG

prednisone

group 2 will remain on 5 mg of prednisone for at least 90 days post transplant.

Sponsors & Collaborators

  • Genzyme, a Sanofi Company

    collaborator INDUSTRY

  • Novartis

    collaborator INDUSTRY

  • Florida Hospital Transplant Center

    lead OTHER

Principal Investigators

  • Michael Angelis, MD · Florida Hospital Transplant Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Completion
2008-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00273559 on ClinicalTrials.gov